The V 0 complex forms the proteolipid pore of an ATPase that acidifies vesicles. In addition, an independent function in membrane fusion has been proposed largely based on yeast vacuolar fusion experiments. We have isolated mutations in the largest V 0 component vha100-1 in flies in an unbiased genetic screen for synaptic malfunction. The protein is only required in neurons, colocalizes with markers for synaptic vesicles as well as active zones, and interacts with t-SNAREs. Loss of vha100-1 leads to vesicle accumulation in synaptic terminals, suggesting a deficit in release. The amplitude of spontaneous release events and release with hypertonic stimulation indicate normal levels of neurotransmitter loading, yet mutant embryos display severe defects in evoked synaptic transmission and FM1-43 uptake. Our data suggest that Vha100-1 functions downstream of SNAREs in synaptic vesicle fusion.
Introduction
Membrane fusion lies at the heart of numerous cell biological processes, most notably vesicle trafficking events underlying cellular function (Jahn, 2004; Jahn et al., 2003; Mayer, 2002) . The basic fusion machinery in virtually all membrane fusion assays analyzed to date relies on SNAREs (soluble NSF-attachment protein receptors) (Jahn, 2004; Südhof, 2004) . The commonly accepted model for a general membrane fusion machinery denotes that membranes are forced into close proximity by the action of SNAREs. In support of this idea, SNAREs have been shown to be sufficient to drive fusion in numerous assays (Hu et al., 2003; Weber et al., 1998) . In contrast to this "proximity model" of membrane fusion, the proteolipid pore-forming V 0 complex has been shown to be required for membrane fusion downstream of SNARE action in a yeast vacuolar fusion assay (Bayer et One of the most intensively studied membrane fusion events is the exocytosis of synaptic vesicles that release neurotransmitter at chemical synapses. Neurotransmitter release is tightly regulated to ensure correct information exchange between neurons and other cells (Südhof, 2004) . Consequently, synaptic vesicle fusion is regulated by a complex machinery in which SNARE proteins play a prominent role (Chen and We have isolated mutations in a neuron-specific VPH1 homolog of the v-ATPase V 0 complex in a forward genetic screen in Drosophila. Mutations in vha100-1 (v100), the fly subunit a1, allow a functional analysis of the role of the V 0 complex in neurons. Here, we report that loss-of-function mutations in vha100-1 indicate a defect late in synaptic vesicle exocytosis. Our data indicate that Vha100-1 is a regulator of synaptic vesicle fusion efficiency downstream of SNARE-dependent vesicle priming.
Results

vha100-1 (v100) Is a Neuronal v-ATPase V 0 Subunit a1
In a forward genetic screen for genes involved in synapse formation and function we identified five EMS (ethyl methane sulfonate)-induced alleles of a complementation group named 3R3 (Mehta et al., 2005; Verstreken et al., 2003). We screened mosaic flies in which chromosome arms carrying randomly induced mutations were made homozygous in the visual system using the eyFLP system (Newsome et al., 2000; Stowers and Schwarz, 1999). Flies with eyes homozygous for any of the five alleles of the 3R3 complementation group consistently fail to walk toward light in a phototaxis assay ( Figure 1A ; Benzer, 1967) . Furthermore, all alleles display defects in electroretinograms (ERGs), extracellular recordings that measure the response of photoreceptor neurons to a light stimulus. Group 3R3 eyFLP mutants respond with a normal depolarization to light stimuli, but exhibit a complete loss of "on" and "off" transients, indicative of a failure to evoke a postsynaptic response (Pak et al., 1969;  Figure 1B ), similar to the ERGs observed in neuronal synaptobrevin (n-syb) and synaptotagmin (syt) mutants (Stowers and Schwarz, 1999; data not shown).
We mapped the lethality associated with complementation group 3R3 to a w50 kb interval at cytological location 98F12 using meiotic recombination mapping with P elements ( Figure 1C Figure  1D , all five alleles contain single-nucleotide changes: v100 1 and v100 4 exhibit altered splice acceptor sites predicted to produce short, truncated proteins; v100 2 and v100 3 cause changes of conserved amino acids in the first transmembrane domain, and v100 5 has a premature stop codon ( Figures 1D, 1E, and 1G ). All mutations fail to complement each other, and all transheterozygous allelic combinations, including any allele over a deficiency (Df(3R)3450; 98E3-99A6) are late embryonic lethal. These data suggest that the five alleles are strong hypomorphic or null alleles. We obtained a cDNA of the v100 transcript CG1709-RC (shown in green in Figure 1D ). Photoreceptor-specific expression of this cDNA rescues the "on" and "off" transients in eyFLP mutants of all alleles, indicating that the ERG phenotypes associated with the eyFLP v100 1-5 mutants are indeed caused by lesions in v100. The photoreceptor-specific rescue of the ERG further suggests a selectively presynaptic requirement of V100 ( Figure 1B) . v100 is a highly conserved subunit of the V 0 subcomplex of the vesicular ATPase. Four similar genes (subunits a1-a4) exist in Drosophila, C. elegans, mouse, and human. Drosophila v100 is more similar to that of the worm, mouse, and human subunit a1 genes (56%, 58%, and 59%, respectively) than to the other subunits a2-a4 ( Figure 1F ).
To determine where v100 is expressed we performed in situ hybridization. The gene is widely expressed in the embryo and the larval nervous system ( Figure 1H ). To test if it is required in tissues other than the nervous system, we expressed the full-length cDNA under control of the neuron-specific elav-GAL4 driver using the GAL4/UAS system (Brand and Perrimon, 1993). Neuron-specific expression of v100 in mutants rescues lethality and results in viable and fertile adult flies with no obvious behavioral defects. Hence, v100 is a v-ATPase subunit that is required in the nervous system. We tested the ability of Drosophila V100 to rescue defects in a DVPH1,DSTV1 double-mutant yeast strain. The double mutant is nonviable on medium at pH 7.5, but can grow at pH 5.5. We therefore tested the ability of v100 to rescue the lethality at pH 7.5, using the rescue with yeast VPH1 as a positive control. As shown in Figure 2A , viability was not rescued with Drosophila v100 at pH 7.5. This result indicates that v100 cannot rescue the acidification defect in yeast.
Drosophila v100
In addition to the acidification defect, DVPH1,DSTV1 double-mutant yeast are also defective in vesicle endocytosis and trafficking as shown in pulse chase experiments with FM4-64 (Perzov et al., 2002) . FM4-64 is a lipophilic dye commonly used to study vesicle trafficking. Wild-type yeast endocytose and transport the dye within minutes from the plasma membrane to the vacuole (Perzov et al., 2002) . We performed pulse chase experiments at both pH 5.5 and pH 7.5 with double mutants transformed with control vector, VPH1, or the experimental vector carrying v100 (Figures 2B-2H) . To quantify the translocation of the dye from the plasma membrane to the vacuole, we imaged the cells every although below the Vph1p levels ( Figure 2B ) at both pH 5.5 and pH 7.5. Taken together, these experiments indicate that V100 can partially compensate for an in vivo endocytosis and vesicle trafficking defect, but not the acidification defect of DVPH1,DSTV1 yeast.
v100 Mutant Synapses Contain Increased Vesicle Numbers
Loss of v100 does not affect photoreceptor viability, development, or their ability to respond to a light stimulus with normal depolarization. These data clearly suggest a lack of general defects in acidification of intracellular compartments or membrane trafficking in these mutants. Hence, the v100 defects indicate a specific impairment in synaptic transmission. Such defects are often associated with ultrastructural defects in synaptic vesicle number and/or shape. To assess synaptic vesicle numbers we performed transmission electron microscopy (TEM) of the first optic neuropil, the lamina. We made use of the eye-specific ey3.5FLP system (Iris Salecker, personal communication; Mehta et al., 2005) to selectively render the presynaptic photoreceptor terminals homozygous mutant in the brain and carried out TEM for four different mutant alleles. As shown in Figures 3A and 3B, photoreceptor projections in the brain of ey3.5FLP v100 mutants do not display obvious defects. However, in the lamina, some aggregates and a subtle localization defect of the photoreceptor-specific cell adhesion molecule Chaoptin (mAb 24B10) can be observed ( Figures 3C and 3D ). The photoreceptor neu- 1 mutant photoreceptor terminals appear normally organized. However, v100 mutant terminals exhibit an w2.5-fold increase in vesicle density compared to control (p < 0.0001; Figure 3L ). In addition, we found a reduction in the number of capitate projections, dynamically active invaginations of the surrounding epithelial glia that have been associated with vesicle endocytosis (p < 0.001; Figure 3N ; arrowheads in Figures 3H-3J ). Some mutant terminals appear to be enlarged (data not shown). In contrast, the numbers of active zones and mitochondria per terminal are unaltered in mutants (Figures 3K and 3M ; arrows and double-arrowheads in Figures 3H-3J ). These defects are similar to the phenotypes associated with loss of the neuronal vesicle-SNARE n-syb which is required for vesicle priming and fusion (Broadie et al., 1995; Deitcher et al., 1998; Hiesinger et al., 1999). To compare the phenotypes associated with loss of n-syb to those of v100, we also performed TEM on n-syb mutant terminals. Loss of n-syb, like the loss of v100, causes embryonic lethality and loss of "on" and "off" transients in eyFLP mosaics (Deitcher et al., 1998; data not shown). n-Syb was further shown to cause an increased number of vesicles at the embryonic neuromuscular junction (NMJ; Broadie et al., 1995). As shown in Figures  3G and 3J and 3K-3N , TEM on laminae of n-syb null photoreceptor terminals exhibited a similar phenotype to v100 mutant terminals: increased vesicle density, reduced number of capitate projections, and normal numbers of active zones and mitochondria. In summary, the TEM phenotypes indicate a specific defect in v100 mutant terminals that leads to an accumulation of vesicles that is very similar to the v-SNARE n-syb mutant phenotype.
V100 Is Enriched in Synaptic Terminals at Active Zones
To investigate the V100 protein localization, we generated a polyclonal antibody against amino acids 1-416.
Anti-V100 immunoreactivity is abundant in the neuropils of the adult brain but is also present in cell bodies ( Figure 4A ). In the lamina, anti-V100 stains cartridges in a donut-like pattern characteristic of the presynaptic photoreceptor terminals, similar to Synaptotagmin (Syt), a synaptic vesicle marker (Figures 4B-4D ). As much of the characterization of the v100 mutant phenotypes was carried out at the NMJ, we investigated the protein localization in wild-type and mutant embryos (22-24 hr). As shown in Figures 4E-4J , the V100 protein is enriched at the embryonic NMJ and in the neuropil of the central nervous system (CNS). Protein levels in v100 1 /Df and other mutant combinations in the CNS neuropil as well as NMJ staining are strongly reduced to a weak punctate staining that is found in all tissues, including control animals ( Figures 4K-4N and S2 ). This suggests that there is either residual protein or some minor nonspecific component that is recognized by the antiserum. In summary, V100 is enriched at synaptic terminals in the embryonic and adult CNS as well as at the NMJ.
All v100 mutations develop as morphologically normal L1 larvae that fail to hatch. When dissected out of the egg case, they do not exhibit contraction waves that progress from anterior to posterior but rather show uncoordinated twitching. The immobile late embryos/ early L1 larvae live for approximately 24-48 hr but cannot be kept alive longer using fluid yeast. To determine if there are morphological defects at the NMJs or aberrant localization of known synaptic markers, we stained NMJs using antibodies against cell adhesion molecules (HRP, Fas2), synaptic vesicle markers (Syt, Cysteine String Protein, n-Syb), target SNAREs (Syntaxin [Syx], SNAP-25), active zone markers (nc82, DPAK) and postsynaptic receptors (GluRII). We did not observe any obvious morphological defects or aberrant protein localization of the analyzed markers ( Figures 4K-4N, S2 , 7A-7F, S4I-S4N, and data not shown). Hence, v100 is either not required for embryonic development or a maternal protein or RNA contribution to the egg is responsible for normal development. We therefore generated maternal knockout (MKO) embryos for v100 1 and v100 2 (Chou and Perrimon, 1992). These embryos display no developmental delay and present the same behavior and morphology as all other mutant allelic combinations (data not shown). In summary, these data indicate that embryonic and NMJ development does not depend on the presence of v100. To define V100 localization inside synaptic boutons at high resolution, we analyzed the colocalization of V100 with vesicle and active zone markers at the L3 larval NMJ using 3D deconvolution of confocal image stacks (see Supplemental Experimental Procedures). These boutons are typically 3-6 µm in diameter. V100 staining inside boutons colocalizes mostly with the vesicle marker Syt (Figures 4O and 4R) . However, we consistently observed an increased V100 staining at active zones labeled with mAb nc82 (Wucherpfennig et al., 2003 ; arrowheads in Figures 4O-4R) . A quantitative colocalization analysis revealed significantly more colocalization of V100 with nc82 than Syt with nc82, indicating an enrichment of V100 relative to Syt at active zones (Figures 4S-4X) . We further analyzed V100 protein content in a vesicle preparation versus membrane fraction . V100 is enriched in the vesicle fraction but is also present in the membrane fraction containing both vesicles and presynaptic membranes ( Figure S3 ). These data indicate that V100 is a synaptically enriched protein that localizes to both synaptic vesicles and active zones. (coil 1, 44-75; coil 2, 90-135 ) that may interact with SNARE proteins. We therefore investigated V100 interactions with SNAREs. First, we tested bacterially produced V100 protein domains that lack the transmembrane regions in GST pull-down assays. As shown in Figure 5A , both GST-V100 and GST-Syx retrieve Histagged SNAP-25. Furthermore, GST-V100 also interacts with His-Syx. In contrast, only GST-Syx, but not GST-V100, pulls down His-n-Syb, indicating that V100 directly interacts with Syx and SNAP-25, the SNAREs at the target membrane, but not with the vesicle-SNARE n-Syb. We then reversed the experiment using GSTSyntaxin to pull down a His-tagged V100 N-terminal fragment of 133 amino acids (amino acids 10-143) containing the two coiled-coil domains ( Figure 1G ). Syx also pulled down this V100 fragment, indicating an N-terminal Syx interaction domain ( Figure 5B ).
V100 Interacts with t-SNAREs
To confirm these interactions, we verified the pulldown results with coimmunoprecipitation assays. Beads were coated with purified IgGs extracted from anti-V100 antiserum and tested for the ability to immunoprecipitate Syx or SNAP-25, either alone or in combination with V100. Consistent with the pull-down results, both Syx and SNAP-25 can be immunoprecipitated in the presence of V100 ( Figure 5C ). Finally, we tested anti-Syx-coated beads for their ability to coimmunoprecipitate native V100 from fly head extract. As shown in Figure 5D , both Syx and V100 are coimmunoprecipitated from head extract (that was cleared of insoluble material and membraneous fragments) with anti-Syx coated beads, indicating that they exist at least partially as a complex in vivo ( Figure 5D ). In summary, these results indicate that V100 and the t-SNAREs SNAP-25 and Syx directly interact.
The in vivo significance of the V100-Syx interaction is supported by the results of a suppressor screen carried out in parallel to our original eyFLP screen. Overexpression of Syx driven by GMR-Gal4 in photoreceptors at low levels (in flies reared at 18°C) causes a rough eye phenotype and high levels of Syx (28°C) cause cell death. We reasoned that loss of a protein required for Syx action may suppress this toxic effect and screened 181 mutants isolated on chromosome arm 3R in the eyFLP screen (Mehta et al., 2005) for suppression of the rough eye phenotype. Eight mutants displayed suppression, two of which are v100 1 and v100 4 , severe loss-of-function alleles (Figures 5E-5J) . In contrast, mutations causing single-amino acid changes in the first transmembrane domain, v100 2 and v100 3 , displayed no suppression (data not shown). This result indicates that overexpressed Syx requires the function of did observe a significant reduction (p < 0.05) in mEPSC frequency in the allelic combination v100 1 /Df ( Figure  6C) . To test the contribution of maternally contributed v100, we measured spontaneous release in v100 1 MKO/ Df embryos that were deficient in maternally contributed v100 protein or mRNA. In these animals, we saw no reduction in mEPSC amplitude but a very severe reduction in mEPSC frequency (very similar to the one for v100 1 /Df) relative to control (p < 0.05). These results suggest that in late-stage embryos that have lost the zygotic contribution, the maternal component has largely disappeared. In summary, our mEPSC analysis indicates that neurotransmitter content is normal in vesicles. However, it leaves open the question whether the reduced mEPSC frequency is a result of the fusion of empty vesicles or an impairment of the fusion process itself.
Since mutant synapses contain loaded vesicles that can be released spontaneously, the defect at the photoreceptor synapse as well as the lack of coordinated movements in the late embryo may be explained by aberrant evoked neurotransmitter release. To test this possibility, we examined EPSCs at the neuromuscular junction evoked by stimulation of the motor nerve supplying muscle 6. As shown in Figures 6D and 6E , we recorded a significant reduction in the mean EPSC amplitudes (p < 0.01) from 712.7 ± 125 pA (SEM; n = 15) in control to 218.3 ± 90 pA (n = 8) in v100 2 /v100 3 mutant embryos. v100 1 /Df mutants exhibit an even more severe phenotype as the mean evoked amplitude is only 94.6 ± 36 pA (n = 9; p < 0.001). Furthermore, v100 1 / Df synapses display a marked increase in transmission failures: 31.1% ± 10.5% relative to 3.3% ± 3.3% (p < 0.005) in control animals ( Figure 6F ). There was no significant difference between the failure rate of v100 2 / v100 3 and wild-type. These data indicate a strong impairment of the synapse to release vesicles upon nerve stimulation. The normal mEPSC size and frequency in v100 2 /v100 3 mutants combined with a significantly reduced evoked response in this allelic combination argue against a defect in vesicle acidification: if the reduction in the evoked response were due to the release of empty vesicles ("shooting blanks"), these unloaded vesicles should be reflected in an equally reduced frequency of spontaneous release events. Therefore, the reduction in evoked release is likely to be due to a reduction in the number of vesicles released per stimulus. This effect may be due to a reduced presynaptic Ca 2+ signal, a reduction of the readily releasable pool of synaptic vesicles, or an impairment in the fusion process. We tested these possibilities using a Ca 2+ -independent stimulation paradigm (Rosenmund and Stevens, 1996) by pressure application of a 3 s pulse of hypertonic sucrose solution (850 mM) at the NMJ in the presence of 1 µM TTX. We detected postsynaptic currents in response to hypertonic solution in wild-type and mutant (v100 2 /v100 3 and v100 1 /Df) animals (data not shown). Furthermore, we tested maternal knockout v100 1 MKO/ Df embryos (the most severe allelic combination) in the presence of reduced Ca 2+ (0.5 mM), and we also observed a response with hypertonic solution, indicating that loaded vesicles are docked and can be released in a Ca 2+ -independent manner ( Figure 6G ). However, we observed fewer responses in mutants than in wild-type. Importantly, the average amplitude of individual events in control and maternal knockout v100 1 MKO/Df embryos is not significantly different (Kolmogorov-Smirnov test, p = 0.94; Figure S4 ). These data indicate that the boutons contain vesicles that are loaded with neurotransmitter and that vesicles can be released by hypertonic stimulation. They also argue that the SNAREs are functional and that vesicles can be primed for release. In addition, our data do not suggest a defect in vesicle acidification. We therefore argue that V100 is required for synaptic vesicle fusion.
FM1-43 Uptake Is Impaired at v100
Mutant Synapses
It has previously been shown that vesicle acidification does not impair uptake of FM1-43 in cerebellar granule cells (Cousin and Nicholls, 1997), in rat hippocampal neuronal slices (Zhou et al., 2000) , and at Drosophila third instar larval NMJs (Kuromi and Kidokoro, 2000) . These studies imply that defective vesicle acidification does not affect synaptic vesicle cycling. Hence, FM1-43 uptake should be normal if v100 mutants were selectively defective in synaptic vesicle acidification. However, if vesicles fail to be released, as indicated by the electrophysiological data, FM1-43 uptake should be impaired. To measure FM1-43 uptake at mutant embryonic NMJs, we developed a new quantitative protocol using the fixable FM1-43FX dye (see Experimental Procedures).
We first labeled NMJs with FM1-43, obtained 3D confocal datasets, and quantified the fluorescence of NMJs of 33 embryo fillets of unstimulated controls. We found an average ratio of FM labeling inside (boutons) to outside (muscle) of 1.55, indicating that the membranous boutons have a significantly higher affinity for FM1-43 even in the absence of active uptake (Figures S5C-S5E) . The average ratio for stimulated controls (n = 47) was found to be 2.23, thus assigning boundaries for minimal and maximal FM uptake ratios ( Figures 7A-7C and 7J). v100 1 /Df and v100 2 /v100 3 animals exhibited intermediate ratios of 1.74 (±0.08) and 1.62 (±0.08), respectively ( Figures 7J and S5I-S5N ). These uptake ratios correspond to 10.8% and 29.7% uptake of the stimulated controls. The values are not significantly different from each other but are significantly lower than control (p < 0.001). In comparison, n-syb null mutant embryos exhibit 44.5% uptake when compared to the stimulated control, which is likewise not significantly different from the v100 mutant embryos but significantly lower than control (p < 0.005; Figures S5F-S5H) . These results indicate that vesicle cycling is substantially reduced in both n-syb and v100 mutants. To test whether this residual vesicle cycling could be attributed to maternally contributed protein in the v100 mutants, we tested maternal knockout embryos. v100 1 MKO/Df synapses display 1.8% FM uptake, which is not significantly different from unstimulated controls ( Figures 7D-7F and 7J) . Lastly, we asked whether selective disruption of vesicle acidification with Bafilomycin A1 (Baf) affects FM uptake in our paradigm. Baf directly acts on the v-ATPase and blocks proton translocation, thus eliminating the proton motive force and neurotransmitter loading (Dröse and Altendorf, 1997). We tested the influence of Baf on FM uptake and found no significant deviation from the stimulated control ( Figures 7G-7J (Figures S4C-S4E) , n-syb (Figures S4F-S4H) , v100 2 /v100 3 (Figures S4I-S4K) , v100 1 /Df (Figures S4L-S4N 
Discussion
Here we report the identification of mutations in v100, the subunit a1 of the v-ATPase V 0 complex in Drosophila. We present an initial characterization of v100 mutant phenotypes that is inconsistent with a role of v100 in acidification only. Our data indicate that V 0 functions in a late step in synaptic vesicle exocytosis. We isolated mutations in v100 based on the specific defect of photoreceptor neurons to evoke a postsynaptic response. Photoreceptors are an excellent "test tube" because they are not required for viability of the fly, and numerous assays can be used to assess morphology and function. Since loss of v100 does not affect photoreceptor specification, development, viability, and the ability to sense light, we surmise that most intracellular vesicle trafficking and acidification pro- Our results only show a late exocytic role for the V 0 subunit a1, while the implication of other V 0 components remains to be tested. Hence, our data is formally consistent with a role of the V 0 subunit a1 outside of the V 0 complex in association with SNAREs. However, to our knowledge, no role outside the V 0 complex has so far been shown for a subunit a in any system. In summary, our data indicate a function for V100 and possibly the V 0 proteolipid pore as a mediator of vesicle release efficiency downstream of SNARE-dependent priming.
Experimental Procedures
Drosophila Strains, Mutagenesis, and Screen y w;; P{ry +t7.2 = neo FRT} 82B isogenized flies were used for mutagenesis and unmutagenized flies used as control animals. All further fly strains are described in detail below. Mutagenesis, electroretinograms, and phototaxis assays were performed as described (Verstreken 
Electrophysiology
All experiments were performed on late-stage embryos within 2-4 hr before hatching. The embryos were selected under halocarbon oil (95, Halocarbon Products, River Edge, New Jersey) for the absence of a GFP-marked balancer chromosome, and the chorion and the vitelline membrane were removed manually using sharp forceps. The embryo dissection was modified from Broadie et al. (1995) and was carried out in calcium-free HL3 saline: 70 mM NaCl, 5 mM KCl, 11 mM MgCl 2 , 10 mM NaHCO 3 , 5 mM trehalose, 115 mM sucrose, 5 mM HEPES. Briefly, the embryo was attached anteriorly and posteriorly to a Sylgard-coated coverslip using cyanoacrylate glue (Histoacryl B|Braun, Aesculap AG, Tuttlingen, Germany). The animal was cut open with a dorsal incision using a broken razor blade; the cut edges were attached to the coverslip with more glue, and the gut was removed to give a flat preparation with access to the body wall muscles and the nerves supplying them. The muscles were then treated with 100 U/ml of Collagenase Type 1A (SigmaAldrich, St. Louis, Missouri) for two minutes to remove the overlying sheath.
Whole-cell patch clamp recordings were made using an Axopatch 200B amplifier from muscle 6 of abdominal segments A2-A4 using thin-walled borosilicate pipettes fire-polished to a resistance of 3-5 M⍀. Series resistance compensation was not used. The patch pipette was filled with a solution of the following composition: 120 mM KCl, 20 mM KOH, 4 mM MgCl 2 , 0.25 mM CaCl 2 , 5 mM EGTA, 24 mM sucrose, 5 mM HEPES, and 4 mM Na 2 ATP. The muscle cells were clamped to −60 mV taking into account the calculated liquid junction potential of 6.7 mV. Conditions for the recording of spontaneous EPSCs, evoked EPSCs, and hypertonic stimulation are available in the Supplemental Experimental Procedures.
FM Uptake
In brief, embryo fillets were exposed to 10 µM FM1-43FX with or without 30 mM K + for a 5 min stimulation period (stimulated and unstimulated control). The samples were subsequently extensively washed with 0 Ca 2+ saline for another 5 min using 0.5 mM EGTA and 1 mM Advasep-7 (Biotium, Hayward, California). Samples were then fixed and stained for another 5 min with concentrated HRP antibody (1:10) in the absence of detergent. HRP recognizes a common epitope of several neuron-specific surface molecules and thus allows us to demarcate the boundaries of the neuronal processes at the NMJ using threshold segmentation ( Figure S4B ). Colabeling of HRP was similarly performed with highly concentrated Cy5-conjugated secondary antibody. Standardized 3D confocal high-resolution datasets were obtained immediately afterwards. The surface of HRP-demarcated boutons was subsequently reconstructed and the average voxel intensity in the FM1-43 channel calculated for the total volumes inside (boutons) and outside (muscle). Finally, inside/outside ratios were calculated and are presented in Figure 7J . 
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